glp 1 and hormone replacement Can therapy support better weight loss outcomes with GLP-1 medications? Emerging research suggests it might. A 2024 study found that postmenopausal women who used hormone therapy (HRT) alongside a GLP-1 Bioidentical Hormone Replacement Therapy |

Bulsiewicz WJ

This is one of the most misleading things about how these patches are marketed

The molecular weight is below that ceiling

The NDA submission was partly based on topline results from the ongoing single location BHV4157-206-RWE study (NCT06529146), in which troriluzole 200 mg administered orally once daily led to a 5070% slower rate of decline from baseline in the functional Scale for the Assessment and Rating of Ataxia (f-SARA) in all SCA genotypes at 3 years compared to an external control arm. Data from the BHV4157-206 study (NCT03701399) also demonstrated disease stabilization in the SCA3 genotype and a reduction in falls in all SCA genotypes compared to placebo over 48 weeks. If approved, troriluzole will be the first and only medication indicated for the treatment of SCA